CN Patent
CN106188060A — 嘧啶并吡咯类化合物、其制备方法、药用组合物及其应用
Assigned to Xiamen University · Expires 2016-12-07 · 9y expired
What this patent protects
本发明涉及一种下面通式I表示的化合物、其立体异构体、其前药、其药学上可接受的盐或其药学上可接受的溶剂合物,其制备方法、含有它的药用组合物及其在制备预防和治疗肿瘤的药物中的用途,其中所述取代基定义见说明书。
USPTO Abstract
本发明涉及一种下面通式I表示的化合物、其立体异构体、其前药、其药学上可接受的盐或其药学上可接受的溶剂合物,其制备方法、含有它的药用组合物及其在制备预防和治疗肿瘤的药物中的用途,其中所述取代基定义见说明书。
Drugs covered by this patent
- Alunbrig (brigatinib) · Takeda
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.